Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Urothelial Carinoma
Sort By
Newest First
1 / 1
1 / 1
Immuno-Oncology
Agilent Announces Update on PD-L1 CE-IVD in Urothelial Carcinoma
Agilent Technologies, Inc
PR-M08-18-NI-082
Aug 21, 2018
